Dermacure Pharmaceuticals

Development and commercialization of pharmaceutical therapies focused on dermatology and cosmetology.

About Dermacure Pharmaceuticals

Dermacure Pharmaceuticals is a Healthcare company. Development and commercialization of pharmaceutical therapies focused on dermatology and cosmetology. Its Indian entity Dermacure Pharmaceuticals Private Limited reported revenue of β‚Ή34.7 Lakh. Dermacure Pharmaceuticals offers products and services including Skin Care Products and Hair Care Products. Its focus areas include Biopharmaceuticals, Therapeutics, Innovative Therapies and Pharmaceuticals.

Company details

Dermacure Pharmaceuticals is recognized as a biopharmaceutical company that is dedicated to the discovery, development, and commercialization of innovative therapies aimed at improving outcomes for patients with skin and hair-related issues. Products are developed using advanced technologies to ensure they are eco-friendly, affordable, and of high quality, with a strong emphasis on dermatology and cosmetology fields. The companys RD efforts are focused on new formulations and life cycle management, while access to safe and effective medicines is prioritized. Additionally, a balanced pipeline supports treatments for various conditions, and customer satisfaction is maintained through commitment to standards. Operations are based in Mumbai, India, with a history of striving for leadership in the sector.

Operational Areas
Key Metrics
  • Indian entity revenue
    ₹34.7 Lakh

    FY 2025 · +122% YoY

  • Indian entity net profit
    ₹26,543

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹35,870

    FY 2025 · 1% margin

Products & Services of Dermacure Pharmaceuticals

Dermacure Pharmaceuticals offers a comprehensive portfolio of products and services, including Skin Care Products and Hair Care Products.

Skin Care Products
Dermatology

Skin care products are developed and commercialized to address various skin-related issues effectively.

Hair Care Products
Cosmetology

Hair care products are provided as part of the company's efforts to improve outcomes for patients with hair conditions.

Board of directors of Dermacure Pharmaceuticals Private Limited (Dermacure Pharmaceuticals)

Dermacure Pharmaceuticals Private Limited is the primary company behind Dermacure Pharmaceuticals. The board of Dermacure Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Bandi Venkata Narasaiah, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Bandi Venkata Narasaiah
DIN 06615047
Director19 Sep 20197 yrs 1 moDermacure Pharmaceuticals Private Limited
Bandi Venkata Sarathbabu
DIN 05236898
Director19 Sep 20197 yrs 1 moDermacure Pharmaceuticals Private Limited

Financials of Dermacure Pharmaceuticals

Figures of Dermacure Pharmaceuticals Private Limited, the primary company behind Dermacure Pharmaceuticals, for FY 2025. Revenue was ₹34.7 Lakh (+122% year on year). Net profit was ₹26,543 (1% margin). EBITDA was ₹35,870 (1% margin). Revenue has grown at a compounded annual rate of -26% over three years.

  • ₹34.7 LakhRevenue · FY 2025 · +122% YoY
  • ₹26,543Net profit · 1% margin
  • ₹35,870EBITDA · 1% margin
  • ₹10,000Paid-up capital
  • -26%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Dermacure Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Dermacure Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dermacure Pharmaceuticals

The primary company behind Dermacure Pharmaceuticals, Dermacure Pharmaceuticals Private Limited, reported revenue of β‚Ή34.7 Lakh for FY 2025, up 122% year on year.

Dermacure Pharmaceuticals is recognized as a biopharmaceutical company that is dedicated to the discovery, development, and commercialization of innovative therapies aimed at improving outcomes for patients with skin and hair-related issues. Products are developed using advanced technologies to ensure they are eco-friendly, affordable, and of high quality, with a strong emphasis on dermatology and cosmetology fields. The companys RD efforts are focused on new formulations and life cycle management, while access to safe and effective medicines is prioritized. Additionally, a balanced pipeline supports treatments for various conditions, and customer satisfaction is maintained through commitment to standards. Operations are based in Mumbai, India, with a history of striving for leadership in the sector.

Dermacure Pharmaceuticals offers Skin Care Products and Hair Care Products.

Dermacure Pharmaceuticals operates through Dermacure Pharmaceuticals Private Limited.

The legal entities of Dermacure Pharmaceuticals currently have 2 directors, including Bandi Venkata Narasaiah, Bandi Venkata Sarathbabu.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available